The countdown of the launch of the absolute winner in the obesity treatment market
The Ildong Pharmaceutical’s obesity treatment ‘Belviq (generic name: lorcaserin)‘, which recently acquired the sale approval from the Ministry of Food and Drug Safety, has attracted attention of the pharmaceutical market.
Since the sibutramine medicines were threw out from the market for the rea...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
